Evidence
1 record1 recordBest grade:Moderate
Nicotinamide Riboside has moderate evidence showing consistent elevation of NAD+ levels and some cardioprotective signals in healthy and older adults. While no major adverse events have been reported, the clinical significance of potential risks remains unclear.
NAD+ levels / cardiovascular markersHealthy adults; older adults · RCTsModerate
NAD+ levels / cardiovascular markers
Healthy adults; older adults · RCTs
Consistent NAD+ elevation; some cardioprotective signals; no major adverse events in trials to date.
Dose: 500 mgDuration: 6–12 weeks
NMN vs NR debate ongoing; both raise NAD+ effectively.
Stacks containing Nicotinamide Riboside (NR)
Explore all →No public stacks include this supplement yet.
Community Insights
Forms & usage▾
How to take it
Take 250-300 mg daily, preferably in the morning with food.
NR chloride (Niagen)
Most studied commercial form.
Safety & trade-offs3▾
Tolerance
Nausea and flushing at higher doses
Context: doses >1000mg
Note
Same theoretical NAD+-fuelled cell proliferation concern as NMN — clinical significance unknown
Cardiovascular
Modest blood pressure lowering — relevant for those on antihypertensives
●High ●Moderate ● Low / note
My notes▾
Sign in to keep a private note on Nicotinamide Riboside (NR).